These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29890775)

  • 1. pSTAT3 Levels Have Divergent Expression Patterns and Associations with Survival in Squamous Cell Carcinoma and Adenocarcinoma of the Oesophagus.
    O' Sullivan KE; Michielsen AJ; O' Regan E; Cathcart MC; Moore G; Breen E; Segurado R; Reynolds JV; Lysaght J; O' Sullivan J
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas.
    Timme S; Ihde S; Fichter CD; Waehle V; Bogatyreva L; Atanasov K; Kohler I; Schöpflin A; Geddert H; Faller G; Klimstra D; Tang L; Reinheckel T; Hauschke D; Busch H; Boerries M; Werner M; Lassmann S
    Oncogene; 2014 Jun; 33(25):3256-66. PubMed ID: 23912451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma.
    Denley SM; Jamieson NB; McCall P; Oien KA; Morton JP; Carter CR; Edwards J; McKay CJ
    J Gastrointest Surg; 2013 May; 17(5):887-98. PubMed ID: 23435739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of CMET is associated with signal transducer and activator of transcription 3 activation and diminished prognosis in oesophageal adenocarcinoma but not in squamous cell carcinoma.
    Mesteri I; Schoppmann SF; Preusser M; Birner P
    Eur J Cancer; 2014 May; 50(7):1354-60. PubMed ID: 24565853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 is involved in esophageal carcinogenesis through regulation of Oct-1.
    Wang Z; Zhu S; Shen M; Liu J; Wang M; Li C; Wang Y; Deng A; Mei Q
    Carcinogenesis; 2013 Mar; 34(3):678-88. PubMed ID: 23172665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the prognostic role of pSTAT3 expression in temporal bone squamous cell carcinoma.
    Marioni G; Nucci R; Marino F; Cappellesso R; Pillon M; Zanoletti E; Giacomelli L; Franchella S; Billo P; Pareschi R; Martini A
    Otol Neurotol; 2013 Oct; 34(8):1476-82. PubMed ID: 24005169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycine-extended gastrin inhibits apoptosis in Barrett's oesophageal and oesophageal adenocarcinoma cells through JAK2/STAT3 activation.
    Beales IL; Ogunwobi OO
    J Mol Endocrinol; 2009 Apr; 42(4):305-18. PubMed ID: 19153190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
    Haura EB; Zheng Z; Song L; Cantor A; Bepler G
    Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual high expression of STAT3 and cyclinD1 is associated with poor prognosis after curative resection of esophageal squamous cell carcinoma.
    Li H; Xiao W; Ma J; Zhang Y; Li R; Ye J; Wang X; Zhong X; Wang S
    Int J Clin Exp Pathol; 2014; 7(11):7989-98. PubMed ID: 25550842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of STAT3 and MAPK phosphorylation, and the protein expression of cyclin D1 in skin squamous cell carcinoma tissues.
    Wu J; Lu WY; Cui LL
    Mol Med Rep; 2015 Dec; 12(6):8129-34. PubMed ID: 26497194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of the Th17-IL-6R/pSTAT3/BATF/RorγT-axis in the tumoural region of adenocarcinoma as compared to squamous cell carcinoma of the lung.
    Balabko L; Andreev K; Burmann N; Schubert M; Mathews M; Trufa DI; Reppert S; Rau T; Schicht M; Sirbu H; Hartmann A; Finotto S
    Sci Rep; 2014 Dec; 4():7396. PubMed ID: 25491772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.
    Yanaihara N; Hirata Y; Yamaguchi N; Noguchi Y; Saito M; Nagata C; Takakura S; Yamada K; Okamoto A
    Mol Carcinog; 2016 May; 55(5):832-41. PubMed ID: 25856562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity.
    Doyle SL; Donohoe CL; Finn SP; Howard JM; Lithander FE; Reynolds JV; Pidgeon GP; Lysaght J
    Am J Gastroenterol; 2012 Feb; 107(2):196-204. PubMed ID: 22146489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification but not translocation of anaplastic lymphoma kinase is a frequent event in oesophageal cancer.
    Schoppmann SF; Streubel B; Birner P
    Eur J Cancer; 2013 May; 49(8):1876-81. PubMed ID: 23490651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
    Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J
    Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
    Koide N; Nishio A; Sato T; Sugiyama A; Miyagawa S
    Am J Gastroenterol; 2004 Sep; 99(9):1667-74. PubMed ID: 15330899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of inflammation-metaplasia-adenocarcinoma sequence and inflammatory microenvironment in esophageal carcinogenesis using surgical rat models.
    Miyashita T; Tajima H; Shah FA; Oshima M; Makino I; Nakagawara H; Kitagawa H; Fujimura T; Harmon JW; Ohta T
    Ann Surg Oncol; 2014 Jun; 21(6):2012-9. PubMed ID: 24526548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray.
    Kim HS; Park YH; Lee J; Ahn JS; Kim J; Shim YM; Kim JH; Park K; Han J; Ahn MJ
    Cancer; 2010 Feb; 116(3):676-85. PubMed ID: 20052735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus.
    Kilic E; Tennstedt P; Högner A; Lebok P; Sauter G; Bokemeyer C; Izbicki JR; Wilczak W
    Virchows Arch; 2016 Apr; 468(4):483-92. PubMed ID: 26818834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ErbB targeting inhibitors repress cell migration of esophageal squamous cell carcinoma and adenocarcinoma cells by distinct signaling pathways.
    Fichter CD; Gudernatsch V; Przypadlo CM; Follo M; Schmidt G; Werner M; Lassmann S
    J Mol Med (Berl); 2014 Nov; 92(11):1209-23. PubMed ID: 25091467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.